Gilead Sciences (GILD) Net Equity Issued and Repurchased (2009 - 2026)
Gilead Sciences (GILD) posted Net Equity Issued and Repurchased of $9 million for Q2 2026, down 66.7% from $27 million a year earlier and down 94.6% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Gilead Sciences was $304 million, down 44.7% year-over-year; for FY2025, it came in at $408 million, down 3.3% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- In prior years, Gilead Sciences' Net Equity Issued and Repurchased was $422 million in FY2024 (+81.9%), $232 million in FY2023 (-24.9%), $309 million in FY2022 (+82.8%) and $169 million in FY2021 (-34.0%).
- The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q2 2024.
- On a year-over-year basis, Net Equity Issued and Repurchased has declined in each of the last four quarters, with growth averaging 114.1% over the last eight quarters.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2023, with growth of 766.7%; the weakest was Q4 2023, with a decline of 85.2%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $166 million (Q1 2026), $32 million (Q4 2025) and $97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 132.74 Bn | 104.74 Bn | 2.84 Bn | -421.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -346.00 Mn |
| Mar 31, 2026 | -253.00 Mn |
| Dec 31, 2025 | -198.00 Mn |
| Sep 30, 2025 | -338.00 Mn |
| Jun 30, 2025 | -500.00 Mn |
| Mar 31, 2025 | -478.00 Mn |
| Dec 31, 2024 | -177.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Jun 30, 2024 | -95.00 Mn |
| Mar 31, 2024 | -254.00 Mn |
| Dec 31, 2023 | -124.00 Mn |
| Sep 30, 2023 | -217.00 Mn |
| Jun 30, 2023 | -124.00 Mn |
| Mar 31, 2023 | -303.00 Mn |
| Dec 31, 2022 | -616.00 Mn |
| Sep 30, 2022 | -144.00 Mn |
| Jun 30, 2022 | -69.00 Mn |
| Mar 31, 2022 | -258.00 Mn |
| Dec 31, 2021 | -37.00 Mn |
| Sep 30, 2021 | -88.00 Mn |
API Access
Gilead Sciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();